NCT05826847

Brief Summary

Ventilator-induced diaphragmatic dysfunction and intensive care unit (ICU)-acquired weakness are two consequences of prolonged mechanical ventilation and critical illness in patients with acute respiratory distress syndrome (ARDS). Both complicate the process of withdrawing mechanical ventilation, increase hospital mortality and cause chronic disability in survivors. During transition from controlled to spontaneous breathing, these complications of critical illness favor an abnormal respiratory pattern and recruit accessory respiratory muscles which may promote additional lung and muscle injury. The type of ventilatory support and positioning may affect the muscle dysfunction and patient-self-inflicted lung injury at spontaneous breathing onset. In that regard, ARDS patients with ventilator-induced diaphragmatic dysfunction and ICU-acquired weakness who are transitioning from controlled to partial ventilatory support probably present an abnormal respiratory pattern which exacerbates lung and muscle injury. Physiological-oriented ventilatory approaches based on prone positioning or semi recumbent positioning with abdominal binding at spontaneous breathing onset, could decrease lung and muscle injury by favoring a better neuromuscular efficiency, and preventing intense inspiratory efforts and high transpulmonary driving pressures, as well as high-magnitude pendelluft. In the current project, in addition to perform a multimodal description of the severity of ventilator-induced diaphragmatic dysfunction and ICU-acquired weakness in prolonged mechanically ventilated ARDS patients, prone positioning and supine plus thoracoabdominal binding at spontaneous breathing onset will be evaluated.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 24, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

December 6, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2025

Completed
Last Updated

September 28, 2026

Status Verified

September 1, 2026

Enrollment Period

1.7 years

First QC Date

March 6, 2023

Last Update Submit

September 23, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • (Randomized Crossover Trial Phase) Pendelluft Magnitude

    Pendelluft magnitude monitored by electrical impedance tomography, analyzed as a continuous variable. Title corrected in September 2026 from "High-Magnitude Pendelluft", as no threshold was prespecified and the sample size calculation was based on a continuous outcome, according to the protocol amendment approved in May 2024.

    One hour on each ventilatory strategy

  • (Randomized Crossover Trial Phase) Neuromechanical Coupling of the Diaphragm

    Ratio between transdiaphragmatic pressure and electrical activity of the diaphragm, measured by an esophageal/gastric catheter. Co-primary outcome with pendelluft magnitude. Prespecified as primary in the ethics-approved protocol and described in the Brief Summary and as a secondary outcome of the Pilot Randomized Trial Phase, but omitted in error from the Crossover Phase outcomes in the original registration. Added in September 2026.

    One hour on each ventilatory strategy

Secondary Outcomes (1)

  • (Randomized Crossover Trial Phase) Respiratory Mechanics Variables

    One hour on each ventilatory strategy

Study Arms (3)

Control Group

ACTIVE COMPARATOR

ARDS patients at spontaneous breathing onset on pressure support ventilation mode in semi-recumbent position at 45º degrees, performed under individualized PEEP applied in random order.

Procedure: Control

Prone Positioning

EXPERIMENTAL

ARDS patients at spontaneous breathing onset on pressure support ventilation mode in prone position, performed under individualized PEEP applied in random order.

Procedure: Prone Positioning

Thoracoabdominal Binding

EXPERIMENTAL

ARDS patients at spontaneous breathing onset on pressure support ventilation mode in semi-recumbent position at 45º degrees using thoracoabdominal binding with the binder's upper edge above the costal margin, performed under individualized PEEP applied in random order.

Procedure: Thoracoabdominal Binding

Interventions

Prone positioning will be performed according to ICU local protocol with trained provider teams.

Prone Positioning

Thoracoabdominal binding will be used in semi-recumbent position (at 45º) and titrated to obtain a approximately 20% decrease in chest wall compliance and 1-3 cm H2O increase in end-expiratory gastric pressure during steady-state breathing

Thoracoabdominal Binding
ControlPROCEDURE

ARDS patients at spontaneous breathing onset on pressure support ventilation mode in supine position at 45º degrees, performed under standard PEEP according to ARDSNet strategy and individualized PEEP applied in random order.

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult ARDS patients with moderate-severe ARDS on controlled protective mechanical ventilation for more than 2 days (modified from "more than 3 days" by the protocol amendment approved in May 2024)
  • Stable hemodynamics
  • Level of consciousness enough to initiate spontaneous breathing

You may not qualify if:

  • Unstable hemodynamics
  • Tracheostomy
  • Abnormal level of consciousness
  • Central nervous system injury
  • Esophageal varices
  • Pregnancy
  • Contraindications for installation of electrical impedance tomography or nasogastric catheter placement
  • Contraindications for prone positioning and thoracoabdominal binding
  • Chronic neuromuscular disorders
  • Obstructive lung disease; intrinsic positive end-expiratory pressure (PEEP) ≥3 cmH₂O (measured without inspiratory effort);
  • Recent-onset sepsis and moderate-to-severe metabolic acidosis;
  • Multi-organ failure with high short-term mortality risk
  • Clinical evidence of respiratory or hemodynamic instability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico Universidad de Chile

Independencia, Chile

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Interventions

Prone Position

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Rodrigo Cornejo

    University of Chile

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Masking of participants, care providers and investigators was not feasible due to the nature of the interventions (body positioning and thoracoabdominal binding). In the multimodal physiological description, diaphragm ultrasound and conventional electromyography were performed by assessors unaware of the results of the other physiological assessments.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Randomized crossover design. Each patient received three 60-minute conditions under pressure support ventilation (control, thoracoabdominal binding and prone positioning) in random order, under individualized PEEP guided by electrical impedance tomography, with 15-minute washout periods between conditions. A multimodal physiological description was performed in the same cohort. A pilot randomized trial phase with an independent cohort was originally planned but was not conducted.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

March 6, 2023

First Posted

April 24, 2023

Study Start

December 6, 2023

Primary Completion

August 28, 2025

Study Completion

August 28, 2025

Last Updated

September 28, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the published results will be available upon reasonable request to the principal investigator, subject to approval by the local ethics committee and a data use agreement.

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning after publication, for 5 years.
Access Criteria
Researchers with a methodologically sound proposal, after ethics committee approval.

Locations